FDA Webview
X
about-us-banner

FDA Related News

Home / Articles / FDA Related News
latest-news-card-1
Medical Devices

Many Ideas to Approve FDA Regulation of AI: Article

Politico explores the many ideas people have for improving FDFA regulation of artificial intelligence.

latest-news-card-1
Human Drugs

FDA Study Analyzes Provider View of Boxed Warnings

CDER reports on research into how healthcare providers view and use Boxed Warnings when making treatment decisions for their patients.

latest-news-card-1
Human Drugs

Denali Aims for Early 2025 Hunter Syndrome BLA

Denali Therapeutics plans to submit a BLA early next year that will seek accelerated approval for DNL310 (tividenofusp alfa) and its use in treating H...

latest-news-card-1
Human Drugs

Guidance on BIMO Data Technical Specifications

FDA releases a guidance entitled Bioresearch Monitoring Technical Conformance Guide Technical Specifications Document that provides current agency sp...

latest-news-card-1
Federal Register

Class 2 for Neuromuscular Tongue Muscle Stimulators

Federal Register notice: FDA classifies neuromuscular tongue muscle stimulators and their use for reducing snoring and obstructive sleep apnea into Cl...

latest-news-card-1
Human Drugs

Feedback Sought on Model-Informed Drug Development

CDER and CBER seek input to help advance the agencys model-informed drug development program.

Biologics

FDA Authorizes Updated Novavax Covid Vaccine

FDA grants an emergency use authorization for an updated version of Novavaxs Covid-19 vaccine that more closely targets currently circulating variants...

latest-news-card-1
Biologics

Emergent Bio Wins Mpox Vaccine Approval

FDA approves an Emergent BioSolutions supplemental BLA for an expanded indication ACAM2000, (smallpox and mpox vaccine, live) to include preventing mp...

latest-news-card-1
Human Drugs

FDA Backs CellProthera Cell Therapy Phase 3 Study

CellProthera says a recent FDA meeting led to their alignment on a planned pivotal Phase 3 trial design for its ProtheraCytes cell therapy for use in ...

latest-news-card-1
Federal Register

ADHD Digital Therapy Devices Put Into Class 2

Federal Register notice: FDA classifies certain digital therapy devices for attention deficit hyperactivity disorder into Class 2.